Jaime Moreno

Jaime Moreno

Auto-generated profile, based on publicly available information

Jaime Moreno

Novo Nordisk A/S, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJaime Moreno
Jaime Moreno
HNHenrik Nielsen
Henrik Nielsen
OWOle Winther
Ole Winther
FTFelix Teufel
Felix Teufel
Protein subcellular location prediction is a widely explored task in bioinformatics because of its importance in proteomics research. We propose DeepLocPro, an extension to the popular method DeepLoc, tailored specifically to archaeal and bacterial organisms. DeepLocPro is a multiclass subcellular location prediction tool for prokaryotic proteins, trained on experimentally verified data curated from UniProt and PSORTdb. DeepLocPro compares favorably to the PSORTb 3.0 ensemble method, surpassing its performance across multiple metrics on our benchmark experiment. The DeepLocPro prediction tool is available online at https://ku.biolib.com/deeplocpro and https://services.healthtech.dtu.dk/services/DeepLocPro-1.0/ .

8 July 2025 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
JJJulie Mie Jacobsen
Julie Mie Jacobsen
JHJens Frey Halling
Jens Frey Halling
IBIda Blom
Ida Blom
JMJaime Moreno Martinez
Jaime Moreno Martinez
BHBjørn Hald
Bjørn Hald
RKRune E. Kuhre
Rune E. Kuhre
CagriSema is a combination of amylin (cagrilintide) and glucagon-like peptide-1 (semaglutide) analogues being developed for weight management. Here, we show that CagriSema blunts metabolic adaptation in rats. Quantifying CagriSema’s action on energy intake and expenditure in rats we observe 12% weight loss with a 39% reduction in food intake. By contrast, pair-feeding causes less-pronounced weight loss, while weight matching requires a 51% decrease in food intake. Therefore, approximately one-third of CagriSema’s weight loss efficacy arises from an effect on energy expenditure, the blunting of metabolic adaptation, which contributes to the successful treatment of obesity.

25 May 2025 in The Journal of Physiology
Verified
Journal Article
Open access
MHMaria Hansen
Maria Hansen
JGJulius E. R. Grothen
Julius E. R. Grothen
AKAnders Karlsen
Anders Karlsen
JMJaime M. Martinez
Jaime M. Martinez
NSNikos Sidiropoulos
Nikos Sidiropoulos
FDFlemming Dela
Flemming Dela
Training can improve insulin sensitivity in individuals with type 2 diabetes, but a clear understanding of the mechanisms remains elusive. To further our knowledge in this area, we aimed to examine the effect of type 2 diabetes and of high‐intensity interval training (HIIT) on the nuclear transcriptional response in skeletal muscle. We performed single‐nucleus RNA‐sequencing (snRNA‐seq) and immunofluorescence analysis on muscle biopsies from the trained and the untrained legs of participants with and without type 2 diabetes, after 2 weeks of one‐legged HIIT on a cycle ergometer. Surprisingly, the type 2 diabetes condition only seemed to have a minor effect on transcriptional activity in myonuclei related to major metabolic pathways when comparing the untrained legs. However, while in particular the type IIA myonuclei in the control group displayed a considerable metabolic response to HIIT, with increases in genes related to glycogen breakdown and glycolysis primarily in the type IIA myonuclei of the trained leg, this response was blunted in the diabetes group, despite a marked increase in glucose clearance in both groups. Additionally, we observed that fibre type distribution assessed by immunofluorescence significantly correlated with the proportion of myonuclei in the snRNA‐seq analysis. In conclusion, the type 2 diabetes condition blunts the metabolic transcriptional response to HIIT in the type IIA myonuclei without affecting the improvement in insulin sensitivity. Additionally, our results indicate that snRNA‐seq can be used as a surrogate marker for fibre type distribution in sedentary middle‐aged adults. image Key points: The study utilized single‐nucleus RNA sequencing (snRNA‐seq) to analyse 38 skeletal muscle biopsies, revealing distinct transcriptional profiles in myonuclei from individuals with and without type 2 diabetes (T2D) after 2 weeks of HIIT. snRNA‐seq identified significant differences in gene expression, with 14 differentially expressed genes (DEGs) in type IIA myonuclei of the control group, specifically related to glycogen breakdown and glycolysis, which were blunted in the T2D group. In the control group, HIIT induced a substantial transcriptional response in type IIA myonuclei, enhancing metabolic pathways associated with insulin sensitivity, while the T2D group showed minimal transcriptional changes despite improved insulin sensitivity. The T2D group exhibited a blunted response in metabolic gene expression, indicating that the training effect on muscle adaptation was significantly impaired compared to healthy controls. Overall, the findings highlight the differential impact of HIIT on muscle metabolism, emphasizing the need for tailored exercise interventions for individuals with T2D.

9 June 2026 in Nature Communications
Verified
Journal Article
Open access
DBDylan M. Belmont-Rausch
Dylan M. Belmont-Rausch
MLMette Q. Ludwig
Mette Q. Ludwig
MBMarie A. Bentsen
Marie A. Bentsen
SHStine N. Hansen
Stine N. Hansen
ASAnna Secher
Anna Secher
TPTune H. Pers
Tune H. Pers
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promise in preclinical models of neurodegeneration, with emerging evidence suggesting these effects may be driven by modulation of neuroinflammation. However, the cellular mechanisms underlying GLP-1RA effects on neuroinflammation remain poorly understood. Here we show, using a mouse model of lipopolysaccharide-induced neuroinflammation, how semaglutide coordinates cellular responses to resolve neuroinflammation. We find that semaglutide in male mice prevents brain infiltration of neutrophils, excessive cytokine release, and suppresses neuroinflammation-associated transcriptional signatures specifically in microglia, endothelial cells, and a subset of pericytes. Mechanistically, we identify a subset of Glp1r-expressing neurons in the dorsal vagal complex that, upon semaglutide treatment, regulate genes involved in anti-inflammatory signaling. Semaglutide-modulated pathways overlap with inflammatory signatures found in human neurodegenerative diseases, including Alzheimer's disease, suggesting broad relevance for conditions involving neuroinflammation. Together, these findings reveal how GLP-1R signaling in male mice orchestrates resolution of neuroinflammation through coordinated multi-cellular programs.

20 May 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JMJaime Moreno
Jaime Moreno
LGLise Lotte Gluud
Lise Lotte Gluud
EGElisabeth D Galsgaard
Elisabeth D Galsgaard
HHHenning Hvid
Henning Hvid
GMGianluca Mazzoni
Gianluca Mazzoni
VDVIVEK DAS
VIVEK DAS
Background: Chronic Kidney Disease (CKD) and Metabolic dysfunction-associated steatohepatitis (MASH) are metabolic fibroinflammatory diseases. Combining single-cell (scRNAseq) and spatial transcriptomics (ST) could give unprecedented molecular disease understanding at single-cell resolution. A more comprehensive analysis of the cell-specific ligand-receptor (L-R) interactions could provide pivotal information about signaling pathways in CKD and MASH. To achieve this, we created an integrative analysis framework in CKD and MASH from two available human cohorts. Results: The analytical framework identified L-R pairs involved in cellular crosstalk in CKD and MASH. Interactions between cell types identified using scRNAseq data were validated by checking the spatial co-presence using the ST data and the co-expression of the communicating targets. Multiple L-R protein pairs identified are known key players in CKD and MASH, while others are novel potential targets previously observed only in animal models. Conclusion: Our study highlights the importance of integrating different modalities of transcriptomic data for a better understanding of the molecular mechanisms. The combination of single-cell resolution from scRNAseq data, combined with tissue slide investigations and visualization of cell-cell interactions obtained through ST, paves the way for the identification of future potential therapeutic targets and developing effective therapies.

24 June 2026 in Hepatology
Verified
Journal Article
Open access
MWMarta Wojciechowska
Marta Wojciechowska
MTMira Thing
Mira Thing
YHYang Hu
Yang Hu
GMGianluca Mazzoni
Gianluca Mazzoni
LHLea Mørch Harder
Lea Mørch Harder
JRJens Rittscher
Jens Rittscher
Histological assessment is foundational to multi-omics studies of liver disease, yet conventional fibrosis staging lacks resolution, and quantitative metrics like collagen proportionate area (CPA) fail to capture tissue architecture. While recent AI-driven approaches offer improved precision, they are proprietary and not accessible to academic research. Here, we present a novel, interpretable AI-based framework for characterising liver fibrosis from picrosirius red (PSR)-stained slides. By identifying distinct data-driven collagen deposition phenotypes (CDPs) which capture distinct morphologies, our method substantially improves the sensitivity and biological specificity of downstream transcriptomic and proteomic analyses compared to CPA and traditional fibrosis scores. Pathway analysis reveals that CDPs 4 and 5 are associated with active extracellular matrix remodelling, while phenotype correlates highlight links to liver functional status. Importantly, selected CDPs demonstrated prognostic associations in the discovery cohort, with attenuation of discrimination in the external validation cohort. All models and tools are made freely available to support transparent and reproducible multi-omics pathology research.